Global Avascular Necrosis Market Growth (Status and Outlook) 2024-2030

Global Avascular Necrosis Market Growth (Status and Outlook) 2024-2030

Avascular necrosis (AVN), also called osteonecrosis or bone infarction, is death of bone tissue due to interruption of the blood supply. Early on there may be no symptoms. Gradually joint pain may develop which may limit the ability to move. Complication may include collapse of the bone or nearby joint surface.

The global Avascular Necrosis market size is projected to grow from US$ 466.1 million in 2023 to US$ 594.1 million in 2030; it is expected to grow at a CAGR of 3.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Avascular Necrosis Industry Forecast” looks at past sales and reviews total world Avascular Necrosis sales in 2023, providing a comprehensive analysis by region and market sector of projected Avascular Necrosis sales for 2024 through 2030. With Avascular Necrosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Avascular Necrosis industry.

This Insight Report provides a comprehensive analysis of the global Avascular Necrosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Avascular Necrosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Avascular Necrosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Avascular Necrosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Avascular Necrosis.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Avascular Necrosis market by product type, application, key players and key regions and countries.

Segmentation by type
Trauma Related Avascular Necrosis (AVN)
Non-Trauma Related Avascular Necrosis (AVN)

Segmentation by application
Hospitals
Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Stryker
Medtronic
Smith and Nephew
Ethicon
Sanofi
Bayer
Pfizer
Merck
Boehringer Ingelheim
Eli Lilly
Aurobindo Pharma
Integra LifeSciences
Zimmer Biomet
Wright Medical
Grifols

Please note: The report will take approximately 2 business days to prepare and deliver.